ARxChange® - A New Approach to Receivables Performance.
ARxChange® - A Patent approach to Organizing, Valuing and Improving Medical Receivables Performance.
ARxChange® - US Patent 7,949,597.
ARxChange® - Federal Patent Granted on Medical Debt Exchange and Matching Service.

ARxChange® (shorthand for "accounts receivable exchange") is TriCap Technology Group's Open-Market Exchange -- the nation's first (and only) medical receivables' open market exchange for real-time asset disposition. With over $8 billion in listings from health systems across the US, TriCap's patented ARxChange® is the nation's marketplace for maximizing medical receivables performance.

The open market exchange eliminates the "cycle" altogether from the revenue cycle by converting the revenue cycle into point-to-point transactional events using the exact same business methods found commonly in the financial sector and most other mature markets. In the ARxChange® marketplace, healthcare providers list all asset classes of medical receivables for fair market consideration. The nation's leading debt servicers assess the assets with which they are most familiar and either guarantee performance to mutually agreed upon benchmarks and/or acquire the asset using ARxChange's market price-setting mechanisms.

As featured by the Healthcare Financial Association, the ARxChange® enhances performance while simultaneously accelerating asset disposition and distribution throughout the market.

 Benefits include:
  • "Cycle-less" revenue cycle
  • Guaranteed margin lift
  • Accelerated cash conversion
  • Enhanced net performance
  • Recaptured insurance dollars
  • Reduced days in cash outstanding
  • Improved transparency, predictability & accountability
  • Reduced uncompensated care
  • Industry-leading assessment management
  • Real-time receivables performance tracking

   The Nation's Marketplace for Maximizing Medical Receivables Performance